Hepatitis A: Symptoms, Transmission, Prevention, and Vaccination

Published on

July 23, 2026

Hepatitis A is a highly contagious viral liver infection. Although it usually causes a self-limiting illness and most people recover completely, it remains an important public health concern because it spreads easily through contaminated food, water, and close personal contact. Fortunately, hepatitis A is entirely preventable through effective vaccination and proper hygiene practices.

Virology & Transmission Pathways

Hepatitis A is caused by the Hepatitis A virus (HAV), a small RNA virus that replicates in liver cells, enters bile, and is excreted in stool. Primary transmission occurs via the fecal-oral route through microscopic ingestion of infected stool.

Infectivity Window: Peak contagiousness occurs during the 2 weeks prior to jaundice or elevated liver enzymes, when viral concentration in stool is highest.
Modes of Exposure: Close household or sexual contact, contaminated food or water supplies, and inadequate hand hygiene.
Environmental Inactivation: Heat food to >185°F (85°C) for ≥1 minute, use a 1:100 household bleach solution for surface disinfection, or rely on standard municipal water chlorination.

Clinical Features & Disease Course

Unlike hepatitis B and C, hepatitis A does not cause chronic hepatitis or a chronic carrier state. Recovery yields lifelong immunity. While generally self-limiting, HAV infection can precipitate acute liver failure in individuals with underlying chronic liver conditions (e.g., HBV, HCV, metabolic dysfunction-associated steatotic liver disease).

Population Focus	Clinical Features & Epidemiology
Pediatric (<6 years)	Most endemic exposure occurs before age 5; >70% are asymptomatic or present with mild symptoms.
Adults (20–39 years)	Account for nearly 50% of reported North American cases, frequently presenting with symptomatic acute illness.
Community Exposure	Approximately 50% of US cases have no identified risk factor, reflecting widespread community transmission.

High-Risk Groups & Occupational Risks

Behavioral & Clinical Vulnerabilities: Men who have sex with men (MSM), individuals using illicit drugs (injection and non-injection), patients with chronic liver disease, and individuals with clotting factor disorders lacking documented immunity.
Occupational Exposures: Food handlers, healthcare and laboratory workers handling HAV, daycare staff, sewage workers, long-term care staff, animal handlers, and military personnel.
Travel & Adoption: International travelers to endemic regions and household contacts/caregivers of international adoptees (vaccinate ≥2 weeks prior to arrival).

Vaccination & Post-Exposure Prophylaxis

The hepatitis A vaccine contains inactivated (non-live) virus, making it safe and unable to cause infection. The ACIP recommends routine immunization for all children starting at 12 months of age, as well as any individual seeking protection.

PEP Strategy	Clinical Indications & Timing
Hepatitis A Vaccine	Preferred post-exposure prophylaxis for healthy individuals aged 1–40 years, administered within 2 weeks of exposure.
Immune Globulin (IG)	Preferred within 2 weeks of exposure for: infants <12 months, adults >40 years, immunocompromised individuals, patients with chronic liver disease, or those with vaccine contraindications.

Bottom Line

Hepatitis A is a preventable, self-limiting viral infection transmitted via the fecal-oral route. Because peak contagion precedes symptomatic onset, childhood immunization starting at 12 months, risk-targeted vaccination, and prompt post-exposure prophylaxis (vaccine or IG within 14 days) are essential to prevent outbreaks and protect vulnerable populations.